Clinical Trials
4 trialsNCT04722575 2025-03-13
NEO-TIM
Fondazione Melanoma Onlus
Phase 2 Active not recruiting
NCT05370807 2023-10-24
RegoMel
Universitair Ziekenhuis Brussel
Phase 2 Unknown
NCT00083239 2007-06-08
Study of Talabostat in Advanced Melanoma
Point Therapeutics
Phase 2 Completed
NCT00083252 2007-06-08
Study of Talabostat and Cisplatin in Advanced Melanoma
Point Therapeutics
Phase 2 Completed